Nike appoints David M. Denton as CFO, effective Aug. 17
NIKE, Inc. named David M. Denton as Executive Vice President and Chief Financial Officer, effective August 17, replacing Matthew Friend. Denton, formerly CFO of Pfizer, Inc., brings extensive experience from Lowe’s Companies, Inc. and CVS Health Corporation. Friend will step down on August 17 and stay through September 4 to assist with the transition, including participating in the Q4 FY26 earnings call on June 30.
*this image is generated using AI for illustrative purposes only.
NIKE, Inc. has appointed David M. Denton as Executive Vice President and Chief Financial Officer, effective August 17. Denton will lead the global finance organization, partnering with President and Chief Executive Officer Elliott Hill to support capital allocation and long-term value creation. Matthew Friend will step down from his role as Executive Vice President and Chief Financial Officer on the same date but will remain with the company through September 4 to facilitate an orderly transition.
Denton joins NIKE, Inc. from Pfizer, Inc., where he served as Chief Financial Officer and Executive Vice President since May 2022. His previous experience includes roles as Chief Financial Officer and Executive Vice President of Lowe’s Companies, Inc. from 2018 to 2022, and two decades at CVS Health Corporation, including as Executive Vice President and Chief Financial Officer. Denton also brings public company governance experience, having served on the Boards of Directors of Haleon and Tapestry.
Leadership Transition Details
The transition occurs as the company shifts from foundational actions to sustained growth through its Sport Offense operating model. Friend will participate in the fourth quarter fiscal 2026 earnings call on June 30, as planned. Hill thanked Friend for his contributions and noted the transition aligns with the company's strategic priorities.
Fourth Quarter Fiscal 2026 Outlook
NIKE, Inc. will report its fourth quarter and fiscal year 2026 results on June 30. The company stated these results will include a benefit from tariff refunds that was not contemplated in its previously provided guidance. Excluding this one-time benefit, fourth quarter results are expected to be generally in line with prior guidance.
| Event | Date |
|---|---|
| New CFO Effective Date | August 17 |
| Outgoing CFO Departure | September 4 |
| Q4 FY26 Earnings Call | June 30 |
How might David Denton's background in retail and pharmaceuticals influence NIKE's capital allocation strategy under the new Sport Offense model?
What specific financial metrics or strategic shifts should investors anticipate when Denton takes the helm in August?
Could the timing of the CFO transition signal broader changes in NIKE's leadership or operational priorities?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
